# J. Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/j-wang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 1 |
| i10-index | 0 |
| Last Known Institution | Peking University |
| OpenAlex ID | https://openalex.org/A5064955355 |
| Works | 1 |

## Researcher papers

- [32P Atezolizumab plus albumin paclitaxel-based regimens is an optional treatment for EGFR-mutant patients with SCLC transformation after EGFR-TKI](https://scholariq.org/papers/32p-atezolizumab-plus-albumin-paclitaxel-based-regimens-is-an-optional-treatment/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [Peking University](https://scholariq.org/institutions/peking-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.